<?xml version="1.0" encoding="UTF-8"?>
<p>An ideal approach for identifying risk factors for COVID-19 would involve random or representative population sampling.
 <sup>
  <xref rid="R3" ref-type="bibr">3</xref>
 </sup> However, in the surveillance efforts that are being developed when an epidemic is unfolding, population-based testing often is limited by laboratory capacity (i.e., due to unprecedented demands for reagents and trained technicians), funding, and political will. The first thoughts of decision makers are to facilitate testing for people with symptoms who became ill recently, either to isolate, or to know which treatment trajectory is necessary if symptoms worsen.
 <sup>
  <xref rid="R1" ref-type="bibr">1</xref>, 
  <xref rid="R2" ref-type="bibr">2</xref>
 </sup>
</p>
